273 related articles for article (PubMed ID: 29879250)
1. Frequency of Treatment Switching for Spironolactone Compared to Oral Tetracycline-Class Antibiotics for Women With Acne: A Retrospective Cohort Study 2010-2016.
Barbieri JS; Choi JK; Mitra N; Margolis DJ
J Drugs Dermatol; 2018 Jun; 17(6):632-638. PubMed ID: 29879250
[TBL] [Abstract][Full Text] [Related]
2. Optimizing the Trial Design for a Comparative Effectiveness Study of Spironolactone versus Oral Antibiotics for Women With Acne: A Delphi Consensus Panel.
Barbieri JS; Margolis DJ
J Drugs Dermatol; 2020 Dec; 19(12):1238-1239. PubMed ID: 33346508
[TBL] [Abstract][Full Text] [Related]
3. Duration of oral tetracycline-class antibiotic therapy and use of topical retinoids for the treatment of acne among general practitioners (GP): A retrospective cohort study.
Barbieri JS; Hoffstad O; Margolis DJ
J Am Acad Dermatol; 2016 Dec; 75(6):1142-1150.e1. PubMed ID: 27502311
[TBL] [Abstract][Full Text] [Related]
4. Oral Antibacterial Therapy for Acne Vulgaris: An Evidence-Based Review.
Bienenfeld A; Nagler AR; Orlow SJ
Am J Clin Dermatol; 2017 Aug; 18(4):469-490. PubMed ID: 28255924
[TBL] [Abstract][Full Text] [Related]
5. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne.
Ozolins M; Eady EA; Avery A; Cunliffe WJ; O'Neill C; Simpson NB; Williams HC
Health Technol Assess; 2005 Jan; 9(1):iii-212. PubMed ID: 15588555
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Sarecycline, a Novel, Once-Daily, Narrow Spectrum Antibiotic for the Treatment of Moderate to Severe Facial Acne Vulgaris: Results of a Phase 2, Dose-Ranging Study.
Leyden JJ; Sniukiene V; Berk DR; Kaoukhov A
J Drugs Dermatol; 2018 Mar; 17(3):333-338. PubMed ID: 29537451
[TBL] [Abstract][Full Text] [Related]
7. Oral Tetracyclines and Acne: A Systematic Review for Dermatologists.
Armstrong AW; Hekmatjah J; Kircik LH
J Drugs Dermatol; 2020 Nov; 19(11):s6-s13. PubMed ID: 33196746
[TBL] [Abstract][Full Text] [Related]
8. Long-term use of spironolactone for acne in women: A case series of 403 patients.
Garg V; Choi JK; James WD; Barbieri JS
J Am Acad Dermatol; 2021 May; 84(5):1348-1355. PubMed ID: 33434594
[TBL] [Abstract][Full Text] [Related]
9. Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials.
Moore A; Green LJ; Bruce S; Sadick N; Tschen E; Werschler P; Cook-Bolden FE; Dhawan SS; Forsha D; Gold MH; Guenthner S; Kempers SE; Kircik LH; Parish JL; Rendon MI; Rich P; Stein-Gold L; Tyring SK; Weiss RA; Nasir A; Schmitz C; Boodhoo TI; Kaoukhov A; Berk DR
J Drugs Dermatol; 2018 Sep; 17(9):987-996. PubMed ID: 30235387
[TBL] [Abstract][Full Text] [Related]
10. A matched cohort study evaluating whether spironolactone or tetracycline-class antibiotic use among female acne patients is associated with breast cancer development risk.
Garate D; Thang CJ; Golovko G; Wilkerson MG; Barbieri JS
Arch Dermatol Res; 2024 May; 316(5):196. PubMed ID: 38775970
[No Abstract] [Full Text] [Related]
11. The use of oral antibiotics in treating acne vulgaris: a new approach.
Farrah G; Tan E
Dermatol Ther; 2016 Sep; 29(5):377-384. PubMed ID: 27306750
[TBL] [Abstract][Full Text] [Related]
12. Real-world drug usage survival of spironolactone versus oral antibiotics for the management of female patients with acne.
Barbieri JS; Choi JK; James WD; Margolis DJ
J Am Acad Dermatol; 2019 Sep; 81(3):848-851. PubMed ID: 30905798
[No Abstract] [Full Text] [Related]
13. Trends in prescribing behavior of systemic agents used in the treatment of acne among dermatologists and nondermatologists: A retrospective analysis, 2004-2013.
Barbieri JS; James WD; Margolis DJ
J Am Acad Dermatol; 2017 Sep; 77(3):456-463.e4. PubMed ID: 28676330
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of tetracyclines in the treatment of acne vulgaris: a review.
Simonart T; Dramaix M; De Maertelaer V
Br J Dermatol; 2008 Feb; 158(2):208-16. PubMed ID: 17986300
[TBL] [Abstract][Full Text] [Related]
15. Spironolactone and topical retinoids in adult female cyclical acne.
Lessner E; Fisher S; Kobraei K; Osleber M; Lessner R; Elliott L; Wesson S
J Drugs Dermatol; 2014 Feb; 13(2):126-9. PubMed ID: 24509960
[TBL] [Abstract][Full Text] [Related]
16. Sarecycline (Seysara) - another oral tetracycline for acne.
Med Lett Drugs Ther; 2019 Mar; 61(1568):43-44. PubMed ID: 31022156
[No Abstract] [Full Text] [Related]
17. Systemic antibiotic therapy of acne vulgaris.
Ochsendorf F
J Dtsch Dermatol Ges; 2006 Oct; 4(10):828-41. PubMed ID: 17010172
[TBL] [Abstract][Full Text] [Related]
18. A propensity score matched cohort study identifying an association of acne, but not oral antibiotic or isotretinoin use, with risk of incident inflammatory bowel disease.
Taylor MT; Margolis DJ; Kwatra SG; Barbieri JS
J Am Acad Dermatol; 2023 Apr; 88(4):841-847. PubMed ID: 36682724
[TBL] [Abstract][Full Text] [Related]
19. Association of pharyngitis with oral antibiotic use for the treatment of acne: a cross-sectional and prospective cohort study.
Margolis DJ; Fanelli M; Kupperman E; Papadopoulos M; Metlay JP; Xie SX; DiRienzo J; Edelstein PH
Arch Dermatol; 2012 Mar; 148(3):326-32. PubMed ID: 22105812
[TBL] [Abstract][Full Text] [Related]
20. Association or lack of association between tetracycline class antibiotics used for acne vulgaris and lupus erythematosus.
Margolis DJ; Hoffstad O; Bilker W
Br J Dermatol; 2007 Sep; 157(3):540-6. PubMed ID: 17596147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
